Nomura Holdings
PRME icon

Nomura Holdings’s Prime Medicine PRME Stock Holding History

Nomura Holdings’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.4K Buy
24,823
+34
+0.1% +$129 ﹤0.01% 1637
2025
Q4 		$86K Sell
24,789
-126
-0.5% -$560 ﹤0.01% 1848
2025
Q3 		$138K Buy
+24,915
New +$101K ﹤0.01% 1798

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Nomura Holdings's PRME Position: Q1 2026 in Review

Nomura Holdings increased its Prime Medicine (PRME) stake by 0.14% in Q1 2026, buying an estimated $129 and bringing the position to 24,823 shares worth $86.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1637.

Nomura Holdings first reported a position in PRME in Q3 2025 and has held it in 3 quarters since. The position peaked at $138K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Nomura Holdings held 24,823 shares of Prime Medicine worth $86.4K as of Q1 2026.
  • Nomura Holdings bought 34 Prime Medicine shares in Q1 2026, an estimated $129.
  • Prime Medicine made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1637 holding.
  • Nomura Holdings first reported a position in Prime Medicine in Q3 2025 and has held it in 3 quarters since.
  • Nomura Holdings's Prime Medicine position peaked at $138K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.